This is the authors' abstract. We don't add key points for this paper.
Background and objective: Diosgenin is a steroidal sapogenin known for its pharmacological properties including anti-inflammatory effects.This study was aimed to evaluate the in vitro anti-photoaging and anti-inflammatory effects of diosgenin on ultraviolet B (UVB) radiation-induced damage on human dermal fibroblasts.Materials and Methods: The UVB-induced HDF cells were treated with diosgenin at concentrations 5 and 10 µM, respectively.Cytotoxicity induced by UVB radiation on pre-treated and post-treated HDF cells were tested.The levels of pro-inflammatory cytokines in HDF cells were determined using ELISA method.Western blot analysis was performed to determine the expressions of inflammatory mediators NF-k$ and MMPs.The concentrations of reduced glutathione (GSH) and malondialdehyde (MDA) were determined in the cell homogenates.Results: Diosgenin significantly (p<0.01)reduced the cytotoxicity induced by UVB on HDF cells.Pro-inflammatory cytokines and expressions of inflammatory mediators were significantly reversed (p<0.01) by diosgenin in a concentration dependent manner.Diosgenin was able to increase the level of GSH and prevent MDA formations. Conclusion:The results proved that diosgenin has protective effects on HDF cells against UVB-induced inflammation.Therefore, this active compound can be recommended for pharmaceutical formulations against UV induced skin inflammation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: